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INTRODUCTION
Brain ischemia induces early and deep inhibition of protein synthesis that is persistent in vulnerable neurons such as CA1 hippocampal and striatal neurons [1] [2] [3] . In this regard, longlasting inhibition of protein synthesis is one of the alterations that best correlates with neuronal injury after ischemia. Indeed, translation recovery is associated with survival, whereas neurons unable to overcome protein synthesis blockade are destined to die [4] . Translation is mainly inhibited via regulation of the initiation and elongation steps, by impairing the activity of certain eukaryotic initiation or elongation factors (eIFs or eEFs). Modulation of the phosphorylation status and/or degradation of these proteins account for their inactivation. For instance, changes in the phosphorylation status of eIF2 , 4E-BP1 or eEF2 are known to modulate the rate of protein synthesis [5] . Phosphorylation of eIF2 by the double-stranded RNA-activated protein kinase-like endoplasmic reticulum (ER) kinase (PERK) is sufficient to abrogate protein synthesis soon after reperfusion following an ischemic episode [6] [7] [8] [9] . In addition, a number of other factors are affected. For instance, depletion of ATP activates eEF2 kinase through AMP kinase in cortical neurons and slows elongation [10] . Furthermore, global cerebral ischemia leads to eIF4G and eIF4E breakdown [11] [12] [13] . Production of NO bursts after ischemia and NO is involved in inflammation, cerebral damage [14] and protein synthesis reduction through eIF2 phosphorylation [15] [16] [17] . Likewise, excitotoxicity is one of the main promoters of neuronal loss after an ischemic episode, and is also known to inhibit protein synthesis [18] [19] [20] [21] ; however the underlying mechanisms are not fully elucidated. The rise in intracellular calcium induced by glutamate activates eEF2 kinase, which in turn phosphorylates eEF2 and results in the transient blockade to NMDA or DEA/NO, cells were incubated with NMDA or DEA/NO for 30 min, medium was changed to MEM/B27 and, 90 min later, cells were incubated with [ 3 H]leucine for 30 min as described above. Medium was removed, proteins were precipitated with trichloroacetic acid and lysates were processed as previously described [20] for the determination of [ 3 H]leucine incorporated into proteins. Results were expressed as dpm in the TCA fraction/mg protein/min.
Measurement of ATP levels
After drug treatments, cells were washed with cold PBS and collected in a 5 mM EDTA, 0.1 M Na 2 HPO 4 , pH 7.5 buffer. After a 5 min spin at 590 X g at 4ºC, pellets were resuspended in 200 µl of the same buffer, sonicated and centrifuged again for 15 min at 10 000 X g at 4ºC. ATP content was determined in the fresh supernatants using an ATP bioluminescent assay kit and following manufacturer's instructions. Samples were run together with a 0.05-8 µM ATP standard curve and luminescence was monitored in an Orion microplate luminometer (Berthold detection system). Relative light units (RLU) were converted to pmols of ATP and results were expressed as nmol ATP/mg protein.
Western blot
Neuron-enriched cultures were treated with NMDA, NMDA+NOS inhibitors, or DEA/NO for 30 min. Ninety minutes later, cultures were washed with cold 10 mM phosphate-buffered saline (PBS) and harvested in radio-immunoprecipitation (RIPA) lysis buffer (10 mM PBS, 1% Igepal AC-630, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate) supplemented with a protease inhibitor cocktail (Complete) and 1 mM sodium orthovanadate. Protein content was determined by the Bradford assay (Bio-Rad Laboratories, München, Germany). Thirty µg of proteins was separated by electrophoresis on 7%, 12% or 17% polyacrylamide gels (for spectrin-eIF4G, eIF2 and 4E-BP1, respectively) in denaturing conditions and transferred to 0.2 µm polyvinylidene difluoride Immun-Blot membranes (BioRad Laboratories, Hercules, CA, USA). Membranes were incubated overnight at 4ºC with the following primary antibodies: goat anti-eIF4G diluted 1:500, goat anti-eIF2 , rabbit antiphospho-eIF2 (Ser 51 ), rabbit anti-4E-BP1 diluted 1:2000, mouse anti-spectrin diluted 1:4000, mouse anti-STAT3 and mouse anti-eIF4E diluted 1:1000. After two washes in Tris buffer containing Tween-20 (T-TBS), membranes were then incubated for 1 h at room temperature with either anti-rabbit, anti-mouse or anti-goat horseradish peroxidase-conjugated antibody. The reaction was visualized using a chemiluminescence detection system based on the luminol reaction. Autoradiograms were scanned with a GS-800 Densitometer scanner (Bio-Rad) and band density was quantified with the Quantity One image analysis software (Bio-Rad). Molecular weight markers are indicated in kDa on the left side of some of the blots shown in the Figures. For the analysis of eIF2 phosphorylation the phosphorylated/total protein ratio was calculated for each sample. Since the molecular weights of spectrin and eIF4G are 240 and 220 kDa, respectively, we decided to use the 90 kDa protein STAT3 of higher MW than tubulin, to check for equal loading, since none of the treatments affected STAT3 expression (not shown). The densities of the 150-145 kDa bands corresponding to cleaved spectrin were quantified together. The spectrin/STAT3 and eIF4G/STAT3 ratios were calculated for each sample. Data from all quantifications are expressed as a percentage of controls. In the case of 4E-BP1, the proportion of each phosphorylated form ( , and ) was calculated as a percentage of total 4E-BP1 as in [32] . 6 10 g/ml leupeptin, 1 g/ml pepstatin A, 10 g/ml antipain, 50 mM sodium fluoride, 10 mM glycerophosphate and 10 mM sodium molybdate; they were then lysed with buffer A containing 0.5% Igepal AC-630 and 0.1% triton X-100. Cell extracts were spun at 12000 X g for 10 min at 4ºC and the supernatants were collected and frozen at -80ºC for further use. Two hundred g of proteins was incubated with 7-methylguanosine triphosphate (m 7 GTP)-Sepharose for 45 min at 4ºC in buffer A containing 0.1 mM GTP. Proteins were eluted from m 7 GTP-Sepharose with SDS loading buffer and subjected to 7.5%-17% SDS-PAGE and Western blot. Membranes were incubated separately with antibodies against eIF4G, eIF4E and 4E-BP1.
Statistical analysis
Results are expressed as mean SEM and the number of replicates (n) is indicated in the legend of each figure. Unless indicated, one-way analysis of variance (ANOVA) with the Bonferroni post-hoc test was performed to evaluate significant differences between groups. Kruskal-Wallis analysis followed by Dunn's test for multiple comparisons was used to compare groups with non-homogenous variance. One symbol indicates P<0.05, two P<0.01 and three P<0.001.
RESULTS

NOS inhibitors protected against NMDA toxicity in mixed and neuron-enriched cultures.
One of our objectives was to determine whether NO participates in NMDA-induced inhibition of protein synthesis in our primary cultures. First, we confirmed that NMDA toxicity was dependent on NO. When testing the effect of several NOS inhibitors we found that the combination of the non-specific NOS inhibitor L-NAME with the specific nNOS inhibitor NPLA at 2 mM and 100 M, respectively provided almost complete protection against transient (30 min) exposure to 35 M NMDA in mixed neuron/glia and neuron-enriched cultures, as assessed by lactate dehydrogenase activity and propidium iodide staining assays (Figs. 1A and 1B) . Further experiments were therefore performed with the NAME+NPLA combination of NOS inhibitors (referred to as NOS inhibitors in the text). Treatment with the above concentrations of NOS inhibitors did not affect neuronal viability (Fig. 1A) . To check for direct NO toxicity, i.e. not induced by NMDA, we performed a dose-response study with DEA/NO, an NO-donor. DEA/NO was applied for 30 min and toxicity was assessed at 24 h. At 40 µM DEA/NO induced similar toxicity to treatment with 35 µM NMDA (Fig. 1C ) and this concentration of DEA/NO was therefore selected to perform further experiments.
NMDA and NO induced protein synthesis failure
We have previously demonstrated that NMDA decreases the protein synthesis rate after 1 h exposure [20] . Here we explored whether transient exposure to NMDA caused long-lasting inhibition of protein synthesis. A time-course study showed that NMDA inhibited by 52 and 43% the incorporation of [ 3 H]leucine into proteins after 30-min exposure in mixed ( Fig. 2A ) and neuron-enriched cultures (Fig. 2B) , respectively. After removal of NMDA, protein synthesis partially recovered but remained significantly lower than in controls 2 h later (i.e. 90 min after NMDA removal) in both mixed ( Fig. 2A) and neuron-enriched cultures (Fig. 2B) . NOS inhibitors were ineffective at 30 min (during NMDA exposure) but did promote complete recovery of protein synthesis at 2 h. Treatment with NOS inhibitors alone had no effect on protein synthesis (Fig. 2B ). DEA/NO also led to a slight reduction of protein synthesis (less than 20%) at the end of a 30-min exposure and the effect was more pronounced 2 h later (33% decrease) in neuron-enriched cultures (Fig. 2C ). Altogether these data suggest that NO impairs translation and contributes to the late phase of protein synthesis inhibition induced by NMDA.
NMDA and NO induced a moderate decrease in ATP content and did not regulate the phosphorylation of eIF2 ATP depletion can induce endoplasmic reticulum stress, which leads to phosphorylation of eIF2 and subsequent inhibition of protein synthesis [15, 42] . Here we evaluated ATP content after the treatments to determine whether ATP depletion was involved in the observed inhibition of protein synthesis. NMDA caused a 26% reduction of ATP levels at the end of the 30-min exposure, and this effect was maintained 2 h later (Fig. 3A) . Although DEA/NO reduced ATP content to 53% after 30-min exposure, this effect was not significantly different from controls 2 h later (Fig. 3B) , thus indicating that in contrast to NMDA the action of NO on ATP is not long-lasting. NOS inhibitors did not prevent the ATP decrease 2 h after NMDA exposure (Fig. 3C ), and this illustrates that NO was not involved in the persistent ATP reduction after NMDA. Our data suggest that the late protein synthesis inhibition caused by NMDA is not mediated by the corresponding ATP reduction. Phosphorylated eIF2 binds to the GDP/GTP exchanger eIF2B and inhibits its function ([reviewed in [30] ). The inability to restore the binding of GTP to eIF2 prevents the formation of new eIF2·GTP·Met-tRNAi ternary complexes and consequently protein synthesis is inhibited. NMDA and NO did not induce eIF2 phosphorylation on Ser 51 (Figs. 3D and 3E), indicating that eIF2 activity was not inhibited. In order to determine whether our cultures might show increased phosphorylation of eIF2 , neurons were treated for 30 min with thapsigargin. This endoplasmic reticulum stress inducer is known to cause eIF2 phosphorylation through PERK activation. Figure 3F shows that thapsigargin triggers eIF2 phosphorylation when compared to control cells.
NMDA and NO led to calpain activation and eIF4G proteolysis
NMDA is known to induce cytosolic calcium increase [10, 20] during the period of exposure. As expected, NMDA activated calpain, a calcium-dependent cysteine protease, which was assessed by the proteolysis of -spectrin (Figs. 4A and 4C). The 240 kDa full-length protein is processed into 150 and 145 kDa fragments by calpain and to 150 kDa and 120 kDa fragments by caspase-3 [43] . NMDA generated the formation of the 145-150 kDa fragments only (Fig. 4A) , this being indicative of calpain-dependent hydrolysis. Furthermore, eIF4G was cleaved 2 h after NMDA exposure (39% decrease, P<0.05; Figs. 4A and 4C). Proteolysis of both spectrin and eIF4G was completely blocked in the presence of NOS inhibitors (Figs. 4A and 4C), thus indicating an NO-dependent mechanism. In agreement with a previous report [39] , NO dramatically stimulated calpain and reduced eIF4G levels by 52% (Figs. 4B and 4D). Several calpain inhibitors (not shown) were then used to determine the contribution of calpain to eIF4G processing, and we found that two of them, calpeptin and MDL28170, completely inhibited calpain activation and blocked the eIF4G degradation induced by NMDA (Figs. 5A and 5C) and DEA/NO (Figs. 5B and 5D ). Therefore, eIF4G degradation was totally dependent on calpain activation.
NMDA and DEA/NO induced the dephosphorylation of 4E-BP1 and abrogated the formation of eIF4F complexes
The formation of eIF4F complexes plays a key role in the regulation of translation initiation. Since eIF4E is a component of the eIF4F complex and it is a rate-limiting translation factor for cap-mRNA, we measured its level of expression, observing that none of the treatments altered its cell content (Fig. 6A) . The phosphorylation status of 4E-BP1 also governs the formation of eIF4F complexes. 4E-BP1 resolves into three electrophoretic forms , and of increasing migration velocity. Only the hyperphosphorylated form of 4E-BP1 does not bind eIF4E [31] and therefore it increases the availability of eIF4E to interact with eIF4G. We studied the phosphorylation of 4E-BP1 and performed a semi-quantitative analysis of the proportion of , and forms with respect to total 4E-BP1 (Fig. 6B and Table 1 ). NMDA was observed to promote a shift from the form to the form (Table 1) , an effect that was abrogated by NOS inhibitors (Fig. 6B and Table 1 ). Furthermore, DEA/NO induced the dephosphorylation of 4E-BP1, illustrated by a decrease in the form and an increase in the form, which is the band of lowest mobility ( Fig. 6B and Table 1 ). In contrast, none of the treatments affected the form. Since eIF4G and 4E-BP1 compete for the same binding site in eIF4E, we evaluated the proteins bound to eIF4E after its purification by m 7 GTP-sepharose affinity chromatography. DEA/NO and NMDA almost completely abolished the interaction between eIF4G and eIF4E, and the NMDA effect was prevented by NOS inhibitors (Fig. 6C) . We also studied whether calpain inhibitors influenced the phosphorylation status of 4E-BP1. Calpeptin and MDL28170 did not reverse the dephosphorylation of 4E-BP1 induced by NMDA and DEA/NO, respectively ( Fig. 6B and Table 1 ). Moreover, calpeptin decreased the form and enhanced the formation of the form compared to NMDA alone ( Fig. 6B and Table 1 ). When the protein synthesis rate was measured, we observed that none of the calpain inhibitors prevented the blockade of protein synthesis induced by NMDA or DEA/NO (Fig.  6D) , thus suggesting that the prevention of eIF4G cleavage alone is not sufficient to abrogate the inhibition of protein synthesis. In contrast, NOS inhibitors that blocked eIF4G processing and dephosphorylation of 4E-BP1 did promote the complete recovery of translation (Figs. 2B, 4C and 6B). In addition, we observed that none of the calpain inhibitors rescued neurons from death (Fig. 6E) , suggesting that survival is compromised when the normal rate of protein synthesis is not achieved.
Rapamycin reduced the formation of eIF4F complexes and inhibited protein synthesis in a similar way to NMDA In order to determine whether hypophosphorylation of 4E-BP1 was by itself sufficient to reduce the formation of eIF4F complexes in the absence of eIF4G degradation, we incubated neurons with rapamycin, an inhibitor of the 4E-BP1 kinase mTOR (reviewed in [30] ). Three hours after addition of rapamycin we observed a dephosphorylation of 4E-BP1 but no loss of eIF4G (Fig. 7A) . When we looked at the amount of eIF4G bound to eIF4E after m 7 GTPsepharose affinity chromatography, we found that rapamycin induced a dose-dependent inhibition of eIF4G binding to eIF4E (Fig. 7B ) that correlated with a decrease in protein synthesis (Fig. 7C ) of similar proportions to that achieved with NMDA (Fig. 6D) .
DISCUSSION
The present study investigated the mechanisms underlying excitotoxicity-mediated translation repression. In particular, we explored the contribution of eIF4G proteolysis and 4E-BP1 dephosphorylation to NMDA-and DEA/NO-induced protein synthesis inhibition. To our knowledge, this is the first study to report molecular changes in translation factors that might be involved in the long-lasting inhibition of protein synthesis after transient exposure to NMDA. We showed that neurons can withstand a transient blockade of translation with limited neuronal loss, and also provided evidence that protein synthesis recovery closely correlates with neuronal survival, as is observed in animal models of stroke [1] . Indeed, the inactivation of NOS enabled full recovery of global protein synthesis, along with an almost complete rescue from NMDA-induced neurotoxicity; this latter finding has been previously reported by other groups [44, 45] . Interestingly, NOS inhibitors were able to prevent the delayed but not the initial inhibition of protein synthesis following NMDA exposure. Similarly, ischemic preconditioning suppresses persistent but not acute inhibition of translation (reviewed in [46] ).
NOS inhibitors did not impede NMDA-induced ATP reduction, despite the fact that they promoted a complete recovery of protein synthesis. Therefore, the moderate decrease in ATP after NMDA and DEA/NO treatments is unlikely to be the cause of protein synthesis inhibition. This result is in agreement with previously published data showing that severe protein synthesis inhibition precedes ATP reduction after treatment with an NO-donor [17] . Furthermore, suppression of protein synthesis occurs in the penumbra where ATP levels are maintained in transient focal ischemia [3] . Interestingly, our data are in accordance with studies suggesting that transient inhibition of protein synthesis is not lethal, whereas the persistent phase of translation suppression is related to neurodegeneration [18, [46] [47] [48] .
Release of calcium from ER stores through blockade of Ca 2+ /ATPase with thapsigargin [17] was shown to induce protein synthesis alterations due to phosphorylation of eIF2 . Glutamate also mobilizes Ca 2+ from ER reservoirs but depresses protein synthesis in an eIF2 phosphorylation-independent manner [19] , in agreement with our data. We did not detect phosphorylation of eIF2 after exposure to DEA/NO, a fast NO-releasing complex, in contrast to previous observations in neuroepithelial cells [16] . S-nitroso-Nacetylpenicillamine (SNAP), a slow NO-releasing agent, has been shown to mobilize thapsigargin-sensitive calcium ER stores in neurons [17] and to phosphorylate eIF2 similarly to thapsigargin in neuroblastoma [15] . The shorter exposure time, faster NO release and lower concentration of NO-donor used in our study may explain the discrepancies with those studies. Therefore, under our experimental conditions DEA/NO inhibited translation by a mechanism that was independent of eIF2 phosphorylation, at least in the late phase. Our data suggest that NO does not contribute to the initial inhibition of protein synthesis by NMDA, but rather takes part in delayed translation deterioration.
Calpain activation and subsequent proteolysis of its substrates is known to occur after excitotoxicity in neurons [22, 39, 43] . While some reports show an attenuation of NMDA toxicity with pharmacological inhibitors of calpain [22] , others have found no protection [43], as we did in the present study. Nevertheless, we found that calpain was responsible for eIF4G breakdown after exposure to NMDA or DEA/NO, in accordance with previous observations in the ischemic brain [13] . Proteolysis of several translation factors has been reported, mainly in apoptotic conditions. Research has shown that eIF2 and 4E-BP1 are the substrate for caspase-3 (reviewed in [23]), while eIF4E and 4E-BP1 are the substrate for calpain in vitro [12, 49] . However, to the best of our knowledge there is no evidence that eIF4E and 4E-BP1 are cleaved by calpain in vivo [12, 49] . Here, we did not observe any degradation of eIF2 , eIF4E or 4E-BP1, suggesting that calpain specifically processed eIF4G in our settings. The eIF4G fragment generated by calpain cleavage does not bind to eIF4E, thus precluding the formation of eIF4F complexes, as shown in both the present study and a model of global cerebral ischemia [32] . Therefore, it is likely that the strong proteolysis of eIF4G contributed to impaired translation in our experimental conditions.
The binding of 4E-BP1 to eIF4E also compromises the association of eIF4F components [24] . We observed that NMDA and DEA/NO insults led to the dephosphorylation of 4E-BP1, which is expected to facilitate its binding to eIF4E. A similar process has been described after global ischemia and was shown to cause a deficit in eIF4E/eIF4G complexes and, therefore, to contribute to translation inhibition [32] . NOS inhibitors enabled the complete recovery of protein synthesis by preventing eIF4G proteolysis and by precluding the dephosphorylation of 4E-BP1. The lack of protein synthesis recovery in the presence of a normal amount of eIF4G (in the presence of calpain inhibitors) suggests that the hypophosphorylation of 4E-BP1 is sufficient to reduce the protein synthesis rate. This result is supported by the data obtained with rapamycin. Rapamycin that dephosphorylated 4E-BP1 but maintained eIF4G integrity reduced the rate of protein synthesis. The rapamycininduced inhibition of translation correlated with the reduced formation of eIF4E/eIF4G complexes. eIF4E is crucial for cap-dependent translation initiation and is a mandatory element of the eIF4F complex since it functions as the cap-binding protein. Reduced availability of eIF4E resulting from protease-mediated degradation or trapping by 4E-BP1 would severely compromise cap-mRNA translation. Therefore, eIF4E is a rate-limiting factor and its sequestration by 4E-BP1 might slowdown the process of translation. The lower amount of full-length eIF4G may worsen the process by decreasing the probability of eIF4E-eIF4G binding. Our data suggest that preventing eIF4G degradation and 4E-BP1 dephosphorylation are necessary to unlock translation repression. The maintenance of eIF4G levels while 4E-BP1 is hypophosphorylated is not sufficient to prevent protein synthesis inhibition. Our results are in agreement with research showing that ischemic tolerance, which promotes translation recovery, tends to prevent eIF4G processing and to favour the phosphorylation of 4E-BP1 [47, 50] .
Since eIF4G and eIF4E play a key role in the translation of cap-mRNAs, we propose that limited availability of both proteins accounts for long-lasting translation failure (summarized in Figure 8 ) and contributes to neuronal loss after NMDA and NO challenges. Further studies are required to unravel the mechanisms controlling 4E-BP1 dephosphorylation. Bottom panels are quantitative analysis of the blots. Band density was measured, the eIF2 -P/eIF2 total ratio was calculated for each sample and results are expressed as % control. Data are mean ± SEM of 11-13 replicates in D and 9-12 replicates in E. Significance for all graphs: *P<0.05, ***P<0.001 vs. control cultures; $$ P<0.01 vs. NMDA-treated cultures. Unpaired t-test was performed for statistical analysis in E. F. Neurons were treated with thapsigargin for 30 min and phosphorylation of eIF2 was examined by Western blot as described in D. C=control, N=NMDA, N+NOSI=NMDA+NOS inhibitors (NAME+NPLA), Thap=thapsigargin.
Figure 4 -spectrin and eIF4G cleavage after NMDA and NO A. NMDA leads to the proteolysis of -spectrin and eIF4G. Neuron cultures were exposed to NMDA or NMDA+NOS inhibitors for 30 min as in Fig 3D. Proteins were separated on 7% SDS-PAGE and processed for eIF4G immunoblotting. Membranes were then reprobed with an antibody recognizing -spectrin. NMDA treatment induced a loss of eIF4G (bottom blot) and of full-length -spectrin and the generation of the 150 kDa spectrin fragment but not of the 120 kDa product (lowest band, top blot). NOS inhibitors impeded spectrin and eIF4G proteolysis. B. Neuron cultures were exposed for 30 min to DEA/NO as in Figure 3E . Proteins were processed for eIF4G and -spectrin Western blot as in A. DEA/NO triggered calpain-mediated breakdown of spectrin (top blot) and eIF4G (bottom blot). Following the stimulation of NMDA receptors, NO is produced and induces the hypophosphorylation of 4E-BP1 and the subsequent binding to eIF4E, thus reducing its availability to interact with eIF4G. Increased intracellular calcium activates calpain that cleaves eIF4G into fragments unable to bind eIF4E. Lower amounts of full-length eIF4G together with the sequestration of eIF4E result in the formation of fewer eIF4E/eIF4G complexes and translation inhibition. Alterations of additional translation factors by regulation of phosphorylation status and/or degradation most likely contribute to achieve the full inhibition of translation. 
